// App-Quantinova.ai

883 : Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis?

Researchers

Presenter

  • F�lix Gibrant Marquez

Principal Investigators

  • Santiago Riviello-Goya

  • Angel Gabriel Vargas Ruiz

  • Edgar Ortz Brizuela

  • Fernando Gil Lpez

  • Alfredo Gutierrez Marn

  • Mara Fernanda Gonzalez Lara

  • Alfredo Ponce de Lon Garduo

  • Jos Sifuentes Osornio

  • Juan Rangel-Patio

Medical Centers

  • Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico city, Mexico

  • Internal Medicine, Instituto Nacional De Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico

  • Hematology Oncology Deparment, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, AG, MEX

  • Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico,

  • Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico

  • Urologic Oncology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, DF, Mexico

  • Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico,

  • Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico,

  • Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved